Table 1.
Baseline Profile of CKD.QLD Patients at the Time of Consent.
| Categories | No. of Patients (%) N=7,201 |
|---|---|
| Sex | |
| Female | 3,317 (46.1) |
| Male | 3,884 (53.9) |
| Age category | |
| <35 y | 390 (5.4) |
| ≥35 to <45 y | 419 (5.8) |
| ≥45 to <55 y | 764 (10.6) |
| ≥55 to <65 y | 1,330 (18.4) |
| ≥65 to <75 y | 2,086 (29.0) |
| ≥75 y | 2,212 (30.7) |
| CKD stages | |
| Stage 1 | 499 (6.9) |
| Stage 2 | 800 (11.1) |
| Stage 3A | 1,339 (18.6) |
| Stage 3B | 2,236 (31.1) |
| Stage 4 | 1,803 (25.0) |
| Stage 5 | 524 (7.3) |
| Indigenous status | |
| Indigenous | 475 (6.6) |
| Nonindigenous | 6,726 (93.4) |
| Proteinuriaa | |
| Normal | 1,776 (28.1) |
| Microproteinuria | 1,960 (31.0) |
| Macroproteinuria | 2,581 (40.9) |
| Primary renal diagnosis | |
| GRD | 376 (5.2) |
| UNC | 800 (11.1) |
| GN | 861 (12.0) |
| Other | 1,178 (16.4) |
| DN | 1,811 (25.2) |
| RV | 2,175 (30.2) |
| People with comorbid conditions | |
| CVD | 5,404 (76.9) |
| Diabetesb | 3,400 (47.2) |
| Cancerc | 1,087 (17.1) |
| Chronic lung diseased | 1,091 (22.5) |
| IRSD quintilese | |
| Lowest | 1,333 (19.1) |
| Low | 1,757 (25.2) |
| Middle | 1,465 (21) |
| High | 1,905 (27.3) |
| Highest | 518 (7.4) |
| BMIf | |
| Underweight | 56 (1.2) |
| Normal | 812 (17.5) |
| Overweight | 1,357 (29.2) |
| Obese | 1,840 (39.6) |
| Morbidly obese | 577 (12.4) |
Abbreviations: BMI, body mass index; CKD, chronic kidney disease; CVD, cardiovascular disease; DN, diabetic nephropathy; GN, glomerular nephropathy; GRD, genetic renal disease; IRSD, Index of Relative Socio-economic Disadvantage; RV, renovascular disease; UNC, unknown cause.
For proteinuria at consent, data available for 6,317 patients.
For diabetes status at the consent, data available for 7,165 patients
For cancer status at consent, data available for 6,372 patients.
For chronic lung disease status at consent, data available for 4,848 patients.
For Index of Relative Socio-economic Disadvantage (IRSD), data available for 6,978 patients. IRSD is the ranks areas in Australia by socioeconomic factors.
For BMI at consent, data available for 4,642 patients.